MPNs

Latest News

Anemia Management in Myelofibrosis: ESAs or Danazol Maintain Ruxolitinib Efficacy
Anemia Management in Myelofibrosis: ESAs or Danazol Maintain Ruxolitinib Efficacy

June 18th 2025

New findings reveal that combining erythropoiesis-stimulating agents with ruxolitinib maintains efficacy in treating myelofibrosis-related anemia.

Asciminib Shows Better Tolerability in Newly Diagnosed CML-CP
Asciminib Shows Better Tolerability in Newly Diagnosed CML-CP

June 18th 2025

Hematocrit Control, QOL Are Priorities in Low-Risk Polycythemia Vera
Hematocrit Control, QOL Are Priorities in Low-Risk Polycythemia Vera

June 17th 2025

Insights From VERIFY: Rusfertide Shows Promise in Polycythemia Vera
Insights From VERIFY: Rusfertide Shows Promise in Polycythemia Vera

June 6th 2025

Rusfertide Shines as New Treatment Option in Polycythemia Vera
Rusfertide Shines as New Treatment Option in Polycythemia Vera

June 2nd 2025

More News